Applying mucosal barrier injury laboratory-confirmed bloodstream infection criteria in patients with solid tumors and hematologic malignancies: A retrospective cohort study looking for the real source of infection.
Ana Carolina Puin da SilvaMichely Fernandes VieiraMaristela Pinheiro FreireLumena VazPatrícia Rodrigues BonazziKarim Yaqub IbrahimMaria Del Pilar Estevez DizPaulo Marcelo Gehm HoffJuliana PereiraVanderson Geraldo RochaDanilo OrtigosoPublished in: Infection control and hospital epidemiology (2022)
We evaluated the interference of the mucosal barrier injury (MBI) laboratory-confirmed bloodstream infection (MBI-LCBI) criteria on the central-line-associated bloodstream infection (CLABSI) incidence density, and the proportion of catheter-related bloodstream infections (CRBSIs) among those classified as MBI. We detected 339 CLABSIs: 15.0% were classified as MBI-LCBIs, and among these, 19.6% were classified as CRBSIs.